Rigel Pharmaceuticals Inc (RIGL)
1.160
+0.07
(+6.41%)
USD |
NASDAQ |
May 02, 16:00
1.155
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Price: 1.160 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 1.09 | 1.16 | 1.08 | 1.160 | 664376.0 |
May 01, 2024 | 1.06 | 1.11 | 1.06 | 1.09 | 746810.0 |
Apr 30, 2024 | 1.07 | 1.110 | 1.04 | 1.05 | 1.046M |
Apr 29, 2024 | 1.13 | 1.15 | 1.06 | 1.07 | 2.123M |
Apr 26, 2024 | 1.10 | 1.125 | 1.08 | 1.10 | 364286.0 |
Apr 25, 2024 | 1.12 | 1.14 | 1.06 | 1.10 | 2.973M |
Apr 24, 2024 | 1.13 | 1.156 | 1.11 | 1.125 | 6.451M |
Apr 23, 2024 | 1.13 | 1.17 | 1.12 | 1.14 | 520000.0 |
Apr 22, 2024 | 1.06 | 1.14 | 1.06 | 1.13 | 3.340M |
Apr 19, 2024 | 1.05 | 1.09 | 1.01 | 1.08 | 812826.0 |
Apr 18, 2024 | 1.12 | 1.12 | 1.05 | 1.05 | 1.238M |
Apr 17, 2024 | 1.14 | 1.160 | 1.105 | 1.11 | 578022.0 |
Apr 16, 2024 | 1.14 | 1.160 | 1.10 | 1.14 | 754958.0 |
Apr 15, 2024 | 1.19 | 1.19 | 1.14 | 1.15 | 768566.0 |
Apr 12, 2024 | 1.21 | 1.24 | 1.18 | 1.20 | 3.747M |
Apr 11, 2024 | 1.24 | 1.265 | 1.22 | 1.23 | 581181.0 |
Apr 10, 2024 | 1.25 | 1.25 | 1.19 | 1.22 | 892384.0 |
Apr 09, 2024 | 1.28 | 1.30 | 1.22 | 1.25 | 3.445M |
Apr 08, 2024 | 1.315 | 1.315 | 1.22 | 1.26 | 6.361M |
Apr 05, 2024 | 1.29 | 1.305 | 1.255 | 1.29 | 1.412M |
Apr 04, 2024 | 1.36 | 1.36 | 1.275 | 1.29 | 857128.0 |
Apr 03, 2024 | 1.31 | 1.36 | 1.30 | 1.33 | 545029.0 |
Apr 02, 2024 | 1.27 | 1.33 | 1.26 | 1.33 | 800840.0 |
Apr 01, 2024 | 1.44 | 1.445 | 1.175 | 1.34 | 3.724M |
Mar 28, 2024 | 1.47 | 1.505 | 1.46 | 1.48 | 782389.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.6703
Minimum
Nov 09 2022
4.93
Maximum
Feb 08 2021
2.171
Average
2.02
Median
May 23 2019
Price Benchmarks
Nektar Therapeutics | 1.67 |
Avid Bioservices Inc | 8.21 |
Stereotaxis Inc | 2.32 |
Cara Therapeutics Inc | 0.7811 |
Blueprint Medicines Corp | 107.00 |
Price Related Metrics
PS Ratio | 1.727 |
Earnings Yield | -12.07% |
Market Cap | 203.42M |